Inventor · disambiguated record
Helen L. Collins
Also filed as: COLLINS HELEN · COLLINS HELEN L
2 granted patents·6 pending applications·3 citations·filing 2016–2024
45Inventor score
Top patents by PatentIndex Score
8 records- 0183US11091555B2Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapyFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·3 cites·20 claims
- 0275US2024317864A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0369US2023287123A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0467US12319738B2Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancerFIVE PRIME THERAPEUTICS INC·Filed 2021·Granted Jun 3, 2025·0 cites·12 claims
- 0560US2021070862A1B7-h4 antibody dosing regimensFIVE PRIME THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0650US2021332137A1Combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0738US2018353512A1Combination therapies for treating b-cell malignanciesGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 0837US2018207164A1Combination therapies for treating cancersGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Helen L. Collins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →